Yu Zhou

Yu Zhou

Auto-generated profile, based on publicly available information

Yu Zhou

Biohybrid Materials, Department of Bioproducts and Biosystems, Aalto University, Aalto, 00076, Finland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2016 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YHYingqin Hou
Yingqin Hou
JYJingsong Yuan
Jingsong Yuan
YZYu Zhou
Yu Zhou
JYJin Yu
Jin Yu
HLHua Lu
Hua Lu

8 January 2019 in ACS Central Science
Verified
Journal Article
Open access
YHYingqin Hou
Yingqin Hou
YZYu Zhou
Yu Zhou
HWHao Wang
Hao Wang
JSJialing Sun
Jialing Sun
RWRuijue Wang
Ruijue Wang
HLHua Lu
Hua Lu
Polymer conjugation is a clinically proven approach to generate long acting protein drugs with decreased immune responses. Although poly(ethylene glycol) (PEG) is one of the most commonly used conjugation partners due to its unstructured conformation, its therapeutic application is limited by its poor biodegradability, propensity to induce an anti-PEG immune response, and the resultant accelerated blood clearance (ABC) effect. Moreover, the prevailing preference of unstructured polymers for protein conjugation still lacks strong animal data support with appropriate control reagents. By using two biodegradable synthetic polypeptides with similar structural compositions (l-P(EG3Glu) and dl-P(EG3Glu)) for site-specific protein modification, in the current study, we systematically investigate the effect of the polymer conformation on the in vivo pharmacological performances of the resulting conjugates. Our results reveal that the conjugate l20K-IFN, interferon (IFN) modified with the helical polypeptide l-P(EG3Glu) shows improved binding affinity, in vitro antiproliferative activity, and in vivo efficacy compared to those modified with the unstructured polypeptide analogue dl-P(EG3Glu) or PEG. Moreover, l20K-IFN triggered significantly less antidrug and antipolymer antibodies than the other two. Importantly, the unusual findings observed in the IFN series are reproduced in a human growth hormone (GH) conjugate series. Subcutaneously infused l20K-GH, GH modified with l-P(EG3Glu), evokes considerably less anti-GH and antipolymer antibodies compared to those modified with dl-P(EG3Glu) or PEG (dl20K-GH or PEG20K-GH). As a result, repeated injections of dl20K-GH or PEG20K-GH, but not l20K-GH, result in a clear ABC effect and significantly diminished drug availability in the blood. Meanwhile, immature mouse bone marrow cells incubated with the helical l20K-GH exhibit decreased drug uptake and secretion of proinflammatory cytokines compared to those treated with one of the other two GH conjugates bearing unstructured polymers. Taken together, the current study highlights an urgent necessity to systematically reassess the pros and cons of choosing unstructured polymers for protein conjugation. Furthermore, our results also lay the foundation for the development of next-generation biohybrid drugs based on helical synthetic polypeptides.

11 January 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YHYingqin Hou
Yingqin Hou
YZYu Zhou
Yu Zhou
HWHao Wang
Hao Wang
RWRuijue Wang
Ruijue Wang
JYJingsong Yuan
Jingsong Yuan
HLHua Lu
Hua Lu

26 October 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
YZYu Zhou
Yu Zhou
SHShuaidong Huo
Shuaidong Huo
MLMark Loznik
Mark Loznik
RGRobert Göstl
Robert Göstl
ABArnold J. Boersma
Arnold J. Boersma
AHAndreas Herrmann
Andreas Herrmann
Ultrasound (US) produces cavitation‐induced mechanical forces stretching and breaking polymer chains in solution. This type of polymer mechanochemistry is widely used for synthetic polymers, but not biomacromolecules, even though US is biocompatible and commonly used for medical therapy as well as in vivo imaging. The ability to control protein activity by US would thus be a major stepping‐stone for these disciplines. Here, we provide the first examples of selective protein activation and deactivation by means of US. Using GFP as a model system, we engineer US sensitivity into proteins by design. The incorporation of long and highly charged domains enables the efficient transfer of force to the protein structure. We then use this principle to activate the catalytic activity of trypsin by inducing the release of its inhibitor. We expect that this concept to switch “on” and “off” protein activity by US will serve as a blueprint to remotely control other bioactive molecules.

17 July 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
Chao MaChao Ma
Chao Ma
JDJingjin Dong
Jingjin Dong
MVMarco Viviani
Marco Viviani
ITIsotta Tulini
Isotta Tulini
NPNicola Pontillo
Nicola Pontillo
Giuseppe PortaleGiuseppe Portale
Giuseppe Portale
Innovative bio-inspired device based on supercharged spider silk nanostructures engineered to efficiently transport protons.

1 January 2014 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
TRTianhua Ren
Tianhua Ren
YQYumei Qiu
Yumei Qiu
WWWeiyun Wu
Weiyun Wu
FXFeng Xiao
Feng Xiao
SYShicai Ye
Shicai Ye
YZYu Zhou
Yu Zhou
To investigate the expression of adenosine A3 receptor (A3AR) in human colonic epithelial cells and the effects of A3AR activation on tumor necrosis factor alpha (TNF-α-) induced inflammation in order to determine its mechanism of action in human colonic epithelial cells, human colonic epithelial cells (HT-29 cells) were treated with different concentrations of 2-Cl-IB-MECA prior to TNF-αstimulation, followed by analysis of NF-κB signaling pathway activation and downstream IL-8 and IL-1βproduction. A3AR mRNA and protein were expressed in HT-29 cells and not altered by changes in TNF-αor 2-Cl-IB-MECA. Pretreatment with 2-Cl-IB-MECA prior to stimulation with TNF-αattenuated NF-κB p65 nuclear translocation as p65 protein decreased in the nucleus of cells and increased in the cytoplasm, inhibited the degradation of IκB-α, and reduced phosphorylated-IκB-αlevel significantly, compared to TNF-α-only-treated groups. Furthermore, 2-Cl-IB-MECA significantly decreased TNF-α-stimulated IL-8 and IL-1βmRNA expression and secretion, compared to the TNF-α-only treated group. These results confirm that A3AR is expressed in human colonic epithelial cells and demonstrate that its activation has an anti-inflammatory effect, through the inhibition of NF-κB signaling pathway, which leads to inhibition of downstream IL-8 and IL-1βexpression. Therefore, A3AR activation may be a potential treatment for gut inflammatory diseases such as inflammatory bowel disease.